Edition:
United States

Genexine Inc (095700.KQ)

095700.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

37,200.00KRW
24 Mar 2017
Change (% chg)

₩700.00 (+1.92%)
Prev Close
₩36,500.00
Open
₩36,350.00
Day's High
₩37,800.00
Day's Low
₩36,350.00
Volume
24,287
Avg. Vol
35,765
52-wk High
₩71,500.00
52-wk Low
₩35,300.00

Latest Key Developments (Source: Significant Developments)

Genexine granted FDA orphan drug designation for GX-H9 in growth hormone deficiency
Wednesday, 16 Nov 2016 08:00am EST 

Genexine Inc <095700.KQ> :Genexine granted FDA orphan drug designation for GX-H9 in growth hormone deficiency.  Full Article

Genexine entered into a clinical research collaboration with Merck & Co
Wednesday, 16 Nov 2016 08:00am EST 

Genexine Inc <095700.KQ> : Genexine - Entered into a clinical research collaboration with Merck & Co., Inc . Genexine-Research collaboration for assessment of co's GX-188E, HPV therapeutic DNA vaccine, in combination with MSD's anti-PD-1 therapy, Keytruda .Genexine - Additional details were not disclosed..  Full Article

Genexine completes private placement for 60 bln won
Sunday, 17 Jul 2016 09:38pm EDT 

Genexine, Inc. <095700.KQ>:Says it completes private placement of 1,176,458 shares of common stock as of July 15, raising proceeds of 60 billion won from the issue.  Full Article

Genexine issues 19.99 bln won worth convertible bonds
Monday, 11 Jul 2016 02:55am EDT 

Genexine <095700.KQ> Inc.:Says it completed issuance of 19.99 billion won worth of overseas convertible bonds as of July 8.  Full Article

Genexine to raise 60 bln won via private placement
Wednesday, 29 Jun 2016 02:21am EDT 

Genexine <095700.KQ> Inc.:Says it will raise about 60 billion won via private placement.  Full Article

Genexine to issue 19.99 bln won worth convertible bonds
Wednesday, 29 Jun 2016 02:00am EDT 

Genexine <095700.KQ> Inc.:Says it will issue the fifth unregistered/unsecured private convertible bonds, raising 19.99 billion won in proceeds for operations.  Full Article

Genexine, completes private placement of common shares
Wednesday, 2 Dec 2015 11:58pm EST 

Genexine, Inc:Completes private placement of 244,498 shares of common stock as of Dec. 3, and raised proceeds of 19,999,936,400 won from the issuance.  Full Article

Genexine, announces private placement of preferred stock
Monday, 16 Nov 2015 12:40am EST 

Genexine, Inc:To issue 244,498 shares of preferred stock through private placement, with par value of 500 won per share, for debt-equity swap.Sets issue price at 81,800 won per share, to raise proceeds of 19,999,936,400 won for operations.  Full Article

Genexine, to set up joint venture
Friday, 16 Oct 2015 04:07am EDT 

Genexine, Inc:To set up a joint venture in China with Tasgen Bio-Tech co.,Ltd.The joint venture will be engaged in development of biological pharmacy business.The new entity will be capitalized at 34,011,000,000 won.To invest 11,337 mln won into the joint venture, to hold 33.33 pct.Expects transaction settlement date of Dec. 31.  Full Article

Genexine, appoints co-chief executive officer
Wednesday, 12 Aug 2015 01:01am EDT 

Genexine, Inc:Appoints Gyung Han Su and Seo Yu Seok as co-chief executive officer of the company, to replace Sung Yeong Cheol, effective Aug. 12.  Full Article

More From Around the Web

BRIEF-Genexine entered into a clinical research collaboration with Merck & Co

* Genexine - Entered into a clinical research collaboration with Merck & Co., Inc